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Abstract
Background: The placenta plays a crucial role during pregnancy for growth and development of the fetus. Less than
optimal placental performance may result in morbidity or even mortality of both mother and fetus. Awareness among
pediatricians, however, of the benefit of placental findings for neonatal care, is limited.
Objectives: To provide a systematic overview of the relation between placental lesions and neonatal outcome.
Data sources: Pubmed database, reference lists of selected publications and important research groups in the field.
Study appraisal and synthesis methods: We systematically searched the Pubmed database for literature on the relation
between placental lesions and fetal and neonatal mortality, neonatal morbidity and neurological outcome. We conducted
three separate searches starting with a search for placental pathology and fetal and neonatal mortality, followed by
placental pathology and neonatal morbidity, and finally placental pathology and neurological development. We limited our
search to full-text articles published in English from January 1995 to October 2013. We refined our search results by
selecting the appropriate articles from the ones found during the initial searches. The first selection was based on the title,
the second on the abstract, and the third on the full article. The quality of the selected articles was determined by using the
Newcastle-Ottawa Quality Assessment Scale.
Results: Placental lesions are one of the main causes of fetal death, where placental lesions consistent with maternal
vascular underperfusion are most important. Several neonatal problems are also associated with placental lesions, whereby
ascending intrauterine infection (with a fetal component) and fetal thrombotic vasculopathy constitute the greatest
problem.
Conclusions: The placenta plays a key role in fetal and neonatal mortality, morbidity, and outcome. Pediatricians should
make an effort to obtain the results of placental examinations.
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Introduction
The placenta is the organ that links mother and fetus during
pregnancy. It plays a crucial role in fetal growth and development
by enabling the exchange of nutrients and oxygen from the mother
to the fetus and removing fetal waste products.[1] The placenta is
an endocrine organ, a site of synthesis and selective transport of
hormones and neurotransmitters. In addition, the placenta forms a
barrier to toxins and infective organisms.[2,3] In recent years,
findings based on placental lesions have contributed to a better
understanding of how the placenta functions. Less than optimal
placental performance may result in morbidity or even mortality
of both mother and fetus. Indeed, there are indications that
placental lesions are the main cause of fetal death.[4] It is also
becoming increasingly clear that impaired placental functioning
can have major implications for the live-born infant. Awareness
among pediatricians, however, of the benefit of placental findings
for neonatal care, is limited. Usually, the results of placental
examinations are only reported back to the obstetrician instead of
also passing it on to the pediatrician. In our opinion, this is a
missed opportunity. Information on placental lesions can often be
helpful towards explaining an abnormal neonatal outcome and
might have consequences for treatment.
This article provides a systematic review of the relation
between placental lesions and neonatal mortality, morbidity, and
neurological development. We summarized the literature pub-
lished on this topic during the past 18 years. Our hypothesis is
that placental examination provides useful information about the
pathophysiological mechanisms that lead to neonatal mortality
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and morbidity. Should this prove to be the case, this information
is important for the pediatrician who should, therefore, be aware




This systematic review was conducted following the PRISMA
guidelines for systematic reviews. A registered systematic review
protocol is not available. Two independent researchers (AMR
and AFB) searched the PubMed database for literature on the
relation between placental lesions and perinatal mortality,
neonatal morbidity, and neurological development. We limited
our search to full-text articles published in English from January
1st 1995 to October 31st 2013. We conducted three separate
searches starting with a search for placental lesions and fetal
and neonatal mortality, followed by placental lesions and
neonatal morbidity, and finally placental lesions and neurological
development.
For the search on placental lesions and fetal and neonatal
mortality, we used the terms (‘‘placental pathology’’ AND ‘‘fetal
death’’) OR (‘‘placental pathology’’ AND ‘‘stillbirth’’) OR (‘‘pla-
cental’’ AND ‘‘causes’’ AND ‘‘stillbirth’’) OR (‘‘placental pathol-
ogy’’ AND ‘‘mortality’’).
For the search on placental lesions and neonatal morbidity, we
used the terms (‘‘placental pathology’’ AND ‘‘morbidity’’) OR
(‘‘placental pathology’’ AND ‘‘neonatal outcome’’) OR (‘‘placental
lesions’’ AND ‘‘morbidity’’) OR (‘‘placental lesions’’ AND ‘‘neo-
natal outcome’’) OR (‘‘placenta’’ AND ‘‘neonatal implications’’)
OR (‘‘placental’’ AND ‘‘lesions’’ AND ‘‘risk factor’’).
For the search on placental lesions and neurological develop-
ment, we used the terms (‘‘placental pathology’’ AND ‘‘neurolog-
ical’’) OR (‘‘placental pathology’’ AND ‘‘neurologic’’) OR (‘‘pla-
cental pathology’’ AND ‘‘cerebral palsy’’) OR (‘‘placental’’ AND
‘‘neurodevelopmental outcome’’) OR (‘‘placental pathology’’ AND
‘‘follow up’’).
Subsequently, we refined our search results by selecting the
appropriate articles from the ones found during the initial searches
in three stages. The first selection was based on the title, the
second on the abstract, and the third on the full-text article.
Review articles on the subject of placental lesions and outcome
were indicated as background articles. We did not use these
articles in the tables, but we did use them in the text of our article.
We were mainly interested in single births, therefore articles
focusing primary on multiple births were excluded. In addition to
the database search, we screened the reference lists of the selected
articles, and the publications of important research groups in the
field.
Quality assessment
We assessed the quality of all the selected studies by means of
the Newcastle-Ottawa Quality Assessment Scale for cohort and
case-control studies. This assessment scale consists of three parts.
For cohort studies these parts include selection, comparability, and
outcome, for case-control studies selection, comparability, and
exposure. The selection part consists of 4 items, with a maximum
of 1 point per item. The comparability part has 1 item, with a
maximum of 2 points for this item. Both the outcome and
exposure parts consist of 3 items, with a maximum of 1 point per
item. This provides a score, ranging from 0–9 points, with 9 points
for the highest quality.
Results
Our first search for placental lesions and perinatal mortality
resulted in 135 articles. The second search for placental lesions
and neonatal morbidity resulted in 55 articles. Our third search for
placental lesions and neurological outcome produced 67 articles.
After removing duplicates, we had a total of 221 articles. We
excluded 117 articles based on their titles. Reasons for exclusion
were studies with patient populations from developing countries or
studies focusing on multiple births. Abstracts or full-text articles
were assessed of the remaining 104 articles. Sixty-three articles
were additionally excluded for the following reasons: no placental
pathology performed, no neonatal outcome, and the studies being
out of scope. By analyzing the reference lists of the remaining 41
articles, and screening publications from important research
groups in the field, we additionally included 14 articles. Finally,
55 studies were included in our systematic review (Figure 1), i.e. 18
studies on perinatal death [4–21], 19 on neonatal morbidity [22–
40], and 18 on neurological outcome.[41–58] Characteristics and
the quality assessment scores of these 55 articles are presented in
Tables 1–3.
Placental pathology
Examination of the placenta can reveal a wide range of
pathologies. For good reproducibility it is necessary that placental
lesions are well defined. Committees of the perinatal section of the
Society for Pediatric Pathology have proposed definitions for
maternal vascular underperfusion, fetal vascular obstructive lesions
(fetal thrombotic vasculopathy), and the amniotic infection
syndrome.[59–61] Definitions and descriptions of additional
pathologies can be found in various textbooks on the pathology
of the placenta.[62–67]
Since we acknowledge the fact that most pediatricians are
unfamiliar with placental lesions and because a wide variety of
terminology is used in the literature, we classified placental
lesions according to the underlying pathology as previously
proposed together with their pathological descriptions in
Table 4.[35,42,59–61,68–71]
Placental lesions and perinatal mortality
Perinatal mortality is defined as death during the perinatal
period. In the 10th Edition of the World Health Organization’s
International Classification of Diseases, the perinatal period is
defined as death from 22 completed weeks of gestation up to 7
days after birth.[72] Fetal deaths form the largest group of
perinatal mortality. In high-income countries one in every 200
infants that reaches 22 weeks’ gestation or more, is stillborn.[73]
Recently, the important role of the placenta in fetal deaths has
become increasingly clear and several studies suggested that
placental pathology is one of the main causes of fetal death
(Table 5). This underscores the importance of examining the
placenta, a fact sorely underestimated by obstetricians and general
pathologists.[16]
In 30% of the cases the cause of stillbirth is unknown.[73] In the
remainder, i.e. the proportion of cases with known cause, most
stillbirths are caused by placental lesions (12–65%, Table 5),
followed by infections and umbilical cord abnormalities. [73] For
lower gestational ages (GAs) (20 to 24 weeks), an unknown cause of
death is most prominent, followed by placental lesions. At higher
GAs, the relative importance of unknown causes decreases and
placental causes increase.[73]
Placental pathology consistent with maternal vascular under-
perfusion is the main contributor to fetal death, ranging from 34 to
38 percent.[4,8,14] This is most prominent during the preterm
Placental Pathology and Neonatal Outcome
PLOS ONE | www.plosone.org 2 February 2014 | Volume 9 | Issue 2 | e89419
period, in pregnancies complicated by hypertensive disorders, with
a strong decline thereafter. During the term period, fetal death is
mainly caused by developmental pathology of placenta parenchy-
ma.[4] We can conclude that a pathological examination of the
placenta is essential for clarifying causes of stillbirths.[5,13,14,19]
The older classification systems for perinatal mortality did not
address placental pathology, or specific placental lesions, as a
separate group. Only in the more recent classification systems is
placental pathology included as a cause of fetal death. In all recent
stillbirth studies placental pathology is designated as one of the
main causes of fetal death.[74,75] The introduction of classifica-
tion systems with placental pathology included as a separate group
might be one of the reasons why recent studies identify placental
pathology as one of the main causes of fetal death. Most of the
placental lesions found in stillbirths, however, are also seen
regularly after live, preterm or term, births.[76] The question
arises whether placental lesions are also related to neonatal and
neurological morbidity.
To summarize, in recent years the role of the placenta in fetal
deaths has become increasingly clear. Placental pathology is one of
the main causes of fetal death, with placental pathology consistent
with maternal vascular underperfusion as the main contributor.
Placental lesions and neonatal morbidity
It has been suggested that placental lesions are also associated
with neonatal morbidity, but the association is less clear than for
fetal mortality. Placental lesions are suggested to be associated with
illness severity shortly after birth, and with a wide range of
neonatal problems (Table 6).
Illness severity shortly after birth can be determined by the
presence of asphyxia, Apgar scores during the first minutes after
birth, and by several clinical variables during the first 24 hours
after birth. Perinatal asphyxia is described to be associated with
placental lesions affecting fetal vascular supply. These lesions were
umbilical cord complications (disrupted velamentous vessels, cord
tear, hypercoiled cord, cord hematoma), chorioamnionitis with
fetal vasculitis, and fetal thrombotic vasculopathy.[31,35] Low
Apgar scores at 1 and 5 minutes are associated with ascending
intrauterine infection and maternal vascular underperfu-
sion.[22,26] Higher illness severity during the first 24 hours after
birth, determined by the Score of Neonatal Acute Physiology
Perinatal Extension (SNAPPE), is associated with placental
pathological findings of fetal thrombotic vasculopathy and
elevated nucleated red blood cells (a sign of hypoxia).[38]
Figure 1.
doi:10.1371/journal.pone.0089419.g001
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Lung development and neonatal respiratory problems, such as
neonatal respiratory distress syndrome (RDS) and bronchopulmo-
nary dysplasia (BPD), are associated with placental inflammation.
There are indications that the incidence of RDS is reduced in
infants exposed to chorioamnionitis (ORs 0.1–0.6, 95% CI: 0.02–
0.8).[23,29,37,77] This beneficial effect may be explained in
several ways. It can be explained by advanced lung maturation in
terms of an early elevation of interleukin-1 beta (IL–1b) in lung
lavage fluid in the presence of chorioamnionitis, which stimulates
the release of corticotrophin-releasing factor and corticotro-
phin.[78,79] These hormones enhance the production of cortisol
which results in accelerated lung maturation and, therefore, a
decrease in the incidence of RDS.[80] Lung maturation is also
explained with animal models of fetal inflammation. Chorioam-
nionitis in the fetal lung induces elevated IL-1, which in turn
increases the amounts of surfactant proteins in parallel with
increases in surfactant lipids in bronchoalveolar lavages. The lung
mesenchymal tissue decreases, which increases the epithelial
surface area and airspace volume of the lung. This results in a
more mature lung structure that contains more surfactant, has
increased compliance, and supports better gas exchange.[77,81,82]
Besides potentially a beneficial effect on lung function imme-
diately after birth, an ascending intrauterine infection can also
have a detrimental effect on the preterm lung, particularly in the
long-term.[77] Chorioamnionitis can promote BPD, with ORs
ranging from 2.0–7.4 (95% CI: 1.2–31.2).[23,26,37,40,77,83]
BPD results from multiple antenatal and postnatal factors (hits)
contributing to disease progression.[84] Despite a healthier initial
condition (less RDS), the pulmonary status worsens during the
postnatal period.[83] This is explained by an increased suscepti-
bility of the lung to postnatal injurious events (second hits).[83–86]
Even so, the relation between respiratory problems and chorio-
amnionitis is difficult to assess, since it is confounded by a variety
of prenatal factors.[85]
Necrotizing enterocolitis (NEC) is a challenging problem in the
neonatal care of, mainly, preterm infants. The etiology of NEC is
still poorly understood, but it is believed to be multifactorial.[87]
Several studies found an association between NEC and placental
lesions, in particular fetal vascular obstructive lesions (fetal
thrombotic vasculopathy, congested villi, coagulation-related
lesions) with ORs ranging from 2.6 to 9.10 (95% CI: 1.13–
15.08).[26,32,33] The presence of ischemia has been proposed as
an explanation for the etiology of NEC. Placental vasculopathy,
which causes uteroplacental insufficiency, may cause fetal circu-
latory adaptive changes to hypoxia, which may result in bowel
ischemia predisposing to NEC.[26]
Retinopathy of prematurity (ROP) is also associated with
placental lesions, in particular with inflammatory lesions with ORs
ranging from 1.8 to 3.1 (95% CI: 1.02–9.5). [26,36,37,39,88] ROP
affects preterm infants and is caused by disorganized growth of
retinal blood vessels which may result in scarring and retinal
detachment. The etiology of ROP is likely to be a multihit
phenomenon. At least part of the multihit is an inflammation-
related pathogenesis, which is thought to be mediated by cytokines
and growth factors present in the newborn’s systemic circula-
tion.[39] The severity of ROP also correlates positively with
ascending intrauterine infection.[88]
Fetal cardiac abnormalities are also thought to be associated
with placental lesions. A six-fold increase in fetal cardiac
abnormalities is reported in the presence of fetal thrombotic
vasculopathy.[34] The most common cardiac abnormalities found
in its presence are ventricular and atrial septal defects, cardio-
megaly, and coarctation of the aorta. It is hypothesized that the
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lesions.[34] The presence of one lesion may lead to the
establishment of the other, through abnormal blood flow which
serves as the common denominator. Another theory is that a
common genetic variation underlies both placental fetal throm-
botic vasculopathy and abnormal development of the heart.[34]
This theory is supported by studies in mice which have shown
placental and cardiac functions to be intimately linked, both
through secretion of placental factors which affect maternal and
fetal circulation and through genes which contribute to the
development of both organ systems.[89] In addition, ascending
intrauterine infection with both maternal and fetal response is
associated with an increased risk for patent ductus arteriosus with
ORs ranging from 1.7 to 5.53 (95% CI: 1.1–19.27).[26,36,40]
To summarize, the most important placental lesions in neonatal
morbidity seem to be ascending intrauterine infection and fetal
thrombotic vasculopathy. Nevertheless, caution is required in
order to interpret these findings properly. Many studies on
neonatal outcome only focus on infectious placental lesions and
fetal thrombotic vasculopathy to the exclusion of other placental
lesions. Thus there may be a bias towards these two lesions,
because chorioamnionitis is a placental lesion well-known to both
gynecologists and pediatricians. Even so, four of the larger studies
including a wide range of placental lesions identified ascending
intrauterine infection and fetal thrombotic vasculopathy as the
most important placental finding with respect to neonatal
morbidity.[22,26,32,40] This may pave the way for early
interventions serving to prevent morbidity. Before such interven-
tions can be defined, however, detailed knowledge of the
pathophysiological mechanisms that lead to neonatal morbidity
is required.
Placental lesions and neurological morbidity
Many prospective and retrospective studies have been conduct-
ed on placental lesions and neurological morbidity (Table 7). Some
of the studies focused on early brain development, while others
focused on neurological and functional outcome as determined by
follow-up testing. However, it is difficult to conduct correlative
studies between placenta lesions and neurologic or psychiatric
Table 4. Overview of placental pathology relevant for understanding perinatal morbidity and mortality.
Diagnosis Pathology and explanation Outcome
Maternal vascular
underperfusion (MVU)
Inadequate spiral artery remodeling or spiral artery pathology
(decidual vasculopathy). Commonly seen in pregnancies
complicated with pre-eclampsia. Expressed by parenchymal
pathology such as placental hypoplasia, increased syncytial knots,
villous agglutination, increased perivillous fibrin, distal villous
hypoplasia, abnormal villous maturity, infarction, retroplacental
hematoma. [59]
Fetal death [4,8,14], CP [48,56]
Umbilical cord complications Obstruction or disruption of the umbilical cord blood flow (e.g.
umbilical cord prolapse, entanglement, knots, disrupted
velamentous vessels, hyper/hypo-coiling). Can lead to fetal
placental vascular stasis resulting in FTV. [35]
Fetal death [21,31], fetal anomalies [24],
asphyxia [31,35], low Apgar score at 1–5
minutes [24,31], RDS [24]
Fetal thrombotic vasculopathy
(FTV)
Thrombosis, recent or remote, in the umbilical cord, chorionic
plate or stem villus vessels and / or secondary degenerative
pathology in the fetal vasculature distal to by thrombosis
obliterated vessels (e.g. avascular chorionic villi). Expressed by
hemorrhagic endovasculopathy, intimal fibrin cushions,
fibromuscular hypertrophy, villous stromal-vascular
karyorrhexis. [60]
Stillbirth [34], asphyxia [35], q illness severity first
24h [38], NEC [32,33], fetal cardiac abnormalities [34],
ventriculomegaly [52], PVL [43], NI [41,42], CP [46]
Distal villous immaturity /
villous maturation defect
Maturation defect of the third trimester placenta characterized
by enlarged chorionic villi with increased numbers of
capillaries, macrophages, and fluid and decreased formation of
vasculosyncytial membranes. As a result the diffusion distance
between intervillous space and fetal capillaries is increased. [68]
Fetal death [4], asphyxia in diabetic pregnancy [68]
Villitis of unknown etiology
(VUE)
Chronic lymphohistiocytic inflammation of the stem- and
chorionic villi, with or without obliterative vasculopathy of
stem villus vessels. [69]
Neonatal infection [22], NI [42,46], NE [45,58]
Ascending intrauterine
infection (AIUI)
Acute chorioamnionitis and chorionitis (maternal response). The
degree of severity can be staged and graded. [61]
Intrapartum death [10], Low Apgar score at 1–5 minute
[22,26,35], neonatal infection [22,26,30,36], QRDS
[23,29,37], BPD [23,26,37,40], qNEC [32], ROP [26,36,37,39], IVH
[26,32,36,37,47], ventriculomegaly [52], CP [52], NE [45,58]
Acute umbilical and chorionic vasculitis (fetal response). The
degree of severity can be staged and graded. [61]
Low Apgar score at 1–5 minute [22,26,35], neonatal infection
[22,26,30,36], QRDS [29,37], BPD [23,26,40], NEC [32],
ROP[26,36,39], IVH [26,30,32,36,47], brain lesions [49],
NI [42,46,54], NE [45,58], disability in development at 2y [54]
Chronic deciduitis Chronic lymphohistiocytic inflammation of placental villi. [70]
Fetal hypoxia Elevated nucleated red blood cells (NRBCs). Only rare NRBCs are
normal after the first trimester. [42]
q illness severity first 24 h [38], NI [42]
Chorangiosis. Diffuse increase in the number of villous capillaries
[71]
Abbreviations: CP - cerebral palsy; RDS - respiratory distress syndrome; NEC - necrotizing enterocolitis; PVL - periventricular leukomalacia; NI - neurological impairment;
NE - neonatal encephalopathy; BPD - bronchopulmonary dysplasia; ROP - retinopathy of prematurity; IVH - intraventricular hemorrhage.
doi:10.1371/journal.pone.0089419.t004
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Table 5. Results of selected studies on perinatal death.







found/ non placental Remarks











Placenta [13] Unexplained stillbirth OR 0.17 (0.04–0.70) After placental assessment
stillbirth less likely to be unexplained









death Cause explained by placental
examination alone
Placenta [12] Stillbirth Proportion 0.12–0.40
(0.08–0.48)
Different classification systems
Placenta [4] Stillbirth Proportion 0.65
(0.61–0.69)
Placental lesions main cause
fetal death





Placenta [17] Stillbirth Proportion 0.42
(0.37–0.47)
19.9% fetal, 13%
maternal, 31.9% no cause
Proportion placental/cord causes
stillbirth







Placental second common cause
stillbirth. Placenta main cause
(26.1%) in antepartum deaths.






Placental examination most valuable test for
determination of cause stillbirth
Placenta [9] placental pathology in
survivors and neonates
who died
No differences in placental
pathology between
survivors and neonates who
died.
Placenta [6] Stillbirths OR: 2.43
(1.12–5.26)
Positive placental pathology in
66% of stillbirths versus 44% in controls.
Placenta [8] Stillbirth Proportion 0.62
(0.56–0.67)
Leading cause intrauterine death
Placenta [5] Evaluation Stillbirth Proportion 0.30
(0.26–0.34)
Most important aspects stillbirth evaluation:
placenta and autopsy
Placenta [20] Stillbirth Proportion 0.50
(0.45–0.55)




























Proportion AIUI in intrapartum death
AIUI [15] Stillbirth Proportion 0.23
(0.16–0.31)
Major relevant condition associated
with death. Chorioamnionits
diagnosed by bacterial cultures
MVU Maternal vascular
underperfusion
[14] Stillbirth Proportion 0.35
(0.27–0.44)
Direct/major contributor fetal death
MVU [4] Stillbirth Proportion 0.34
(0.30–0.38)
Most important placental lesions in
fetal death
MVU [8] Stillbirth Proportion 0.38
(0.31–0.45)
Main contributor placental lesions to death
Placental Pathology and Neonatal Outcome
PLOS ONE | www.plosone.org 11 February 2014 | Volume 9 | Issue 2 | e89419
outcomes in the child.[90] Neurological outcomes are not evident
immediately after birth, but only long after most placentas have
been discarded. Placentas, especially those of term infants, are not
routinely sent to the pathologist for examination.[55,90] Unless
studied prospectively, infants whose placentas are examined, form
a biased group.[90]
It is thought that the pathogenesis of neurological impairment
has an antenatal as well as an intra-partum component. An event
weeks before delivery can result in a non-optimal fetal environ-
ment. This might result in lowering the threshold required for
more recent events to cause brain injury. Placental lesions can be
such an antenatal event.[41,42,45]
Regarding short-term neurological outcome of preterm infants
in particular, most studies focused on white matter diseases
(periventricular leukomalacia, PVL) and intraventricular hemor-
rhages (IVH). The results are inconsistent as far as the relation
between these short term neurological outcomes and placental
lesions is concerned. Several studies did find a relation between
IVH and histological ascending intrauterine infection (maternal
and fetal response) with ORs ranging from 1.7 to 2.2 (95% CI
1.01–23).[26,30,32,36,47] In addition, the severity of ascending
intrauterine infection is significantly higher among infants with
IVH.[37] After adjusting for gestational age, however, the severity
of ascending intrauterine infection did not seem to affect the
occurrence of IVH. Others were not able to find a relation
between IVH and AIUI.[29,40] There are no indications that
other placental lesions are associated with IVH.
Regarding white matter injury, several studies failed to find a
relation with histological AIUI (maternal and fetal response).[43,51]
Nevertheless, in a meta-analysis, ascending intrauterine infection
(clinical and histological) was indicated as a risk factor for white
matter injury in preterm infants, with a relative risk of
approximately 2.1.[91] The authors hypothesized that elevated
cytokine levels play a role in the etiology of white matter brain
lesions. The reason for the inconsistency of the results may be
ascribed to differences in adjusting for potential confounders.
Wu et al.[91] explained the effect of adjusting for gestational
age. Although gestational age appears to be a possible
confounder, it may also lie directly in the causal pathway
between maternal infection and cerebral palsy (CP). Chorioam-
nionitis is associated with preterm delivery, and low gestational
age is in turn associated with a host of intrinsic vulnerabilities
within the brain that have been implicated in the pathogenesis
of cystic PVL and CP. Therefore, if low gestational age
resulting from maternal infection in itself plays a direct role in
the pathogenesis of CP, then adjusting for its effect will falsely
diminish the observed association between chorioamnionitis and
CP.[91]
Neonatal encephalopathy has mainly an antepartum, rather
than an intrapartum, etiology. An important antepartum factor is
placental pathology.[45,58] Placental lesions consistent with fetal
thrombotic vasculopathy (OR 4.63, 95% CI: 2.01–10.68) and
AIUI with a fetal response (funisitis) (OR 22.54 95% CI: 11.07–
45.91) are both associated with neonatal encephalopathy.[45,58]
Another less strongly associated placental lesion is accelerated
villous maturation (disturbed uteroplacental flow) with an OR of
3.86 (95% CI: 1.36–10.92).[45]
Elbers et el. studied placental pathology in relation to neonatal
stroke.[53] They systematically described their findings in twelve
cases of neonatal stroke, ten of which had placental lesions. They
found the following types of lesions: thromboinflammatory process
in six cases, sudden catastrophic event in five cases, decreased
placental reserve in three cases, and stressful intrauterine
environment in two cases. They suggested that multiple risk
factors are involved in neonatal stroke, and that placental
pathology may be a contributing factor.[53]
The Extremely Low Gestational Age Newborns (ELGAN)
investigators studied the predictive value of placental pathology in
regard to white matter damage and later CP. They found
histologic inflammation to be predictive of ventriculomegaly and
diplegic CP, with ORs ranging from 1.4 to 1.5 (95% CI: 1.0–2.4)
and ORs 2.3–3.4 (95% CI: 1.1–7.4), respectively. Placental
inflammation was not predictive for echolucent lesions.[52] Also
fetal thrombotic vasculopathy is found to be associated with CP. In
the presence of FTV and CP, obstructive umbilical cord
abnormalities have been identified. These umbilical cord abnor-
malities can lead to fetal placental vascular stasis resulting in fetal
thrombotic vasculopathy.[42,46,92] Macroscopic examination of
the placenta can also identify an increased risk of CP. Placental
infarction thus identified is associated with an increased risk of the
spastic quadriplegic subtype of CP (OR 2.6, 95% CI: 1.2–5.6).[56]
The pathophysiological mechanism of placental infarction leading
to CP is not clear. It is stated that because of the many functions
and substantial functional reserve of the placenta, it cannot be
assumed that placental infarction acts mainly by interference with
gas exchange. A hypothesis is that, whatever the underlying
Table 5. Cont.







found/ non placental Remarks
UC Umbilical cord
lesions
[15] Stillbirth Proportion 0.05 (0.02–
0.10)
Proportion UC pathology in stillbirth
UC Umbilical cord
complication
[21] Stillbirth Proportion 0.08 (0.06–
0.10)
Significant more in term stillbirths (9.75)
compared to preterm stillbirths (6.4%)
UC Undercoiling
umbilical cord
[31] Fetal death OR 3.35 (1.48–7.63)
UC Overcoiling
umbilical cord
[31] Fetal death Not significant. OR 2.43
(0.68–8.66)
UC Excessive long UC [24] Fetal/neonatal death Not significant. OR 2.75
(0.65–36.14)
*proportion placental lesions in perinatal death.
Abbreviations: AIUI - ascending intrauterine infection; MVU - maternal vascular underperfusion; UC - umbilical cord.
doi:10.1371/journal.pone.0089419.t005
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AIUI Maternal + fetal
response




AIUI (not specified) [38] Illness severity first
24h
No relation
AIUI [22,26,30,32,36] Neonatal infection OR 1.7–1.9 (1.2–3.0) Effect size r= 0.31 [36] No relation [32] EOS + LOS +
nosocomial infection
AIUI [23,26,32] RDS OR 0.11 (0.02–0.63) No relation [26,32]
AIUI [23,26,32,40] BPD OR 2.0–7.4 (1.20–31.16) No relation [32]
AIUI [25] BPD OR 0.7 (0.4–0.9) Unadjusted GA ns
AIUI [26,30,32,36,40] PDA OR 1.7–5.53 (1.1–19.27) Effect size r= 0.25 [36] No relation [32,30]
AIUI [26,36,39,40] ROP OR 1.8–3.1 (1.02–9.5) Effect size r= 0.52[36] No relation [40] In combination with
micro-organisms
[39]
AIUI [26,32,40] NEC OR 3.80 (1.67–8.67) No relation [26,40]
AIUI [28] Fetal metabolic
acidosis
No relation
AIUI [22] Liver disorders No relation






AIUI [35] Asphyxia Proportion: 0.22 95%
CI (0.10–0.42)
Proportion AIUI
[37] Sepsis No relation Stage AIUI
AIUI [29,37] RDS OR 0.6 (0.5–0.8) Proportion RDS: 0.44
95% CI (0.35–0.53) [29]
Significant less than
control group
AIUI [29,37] BPD 59% with BPD had
AIUI [37] Proportion
BPD 0.26 95% CI
(0.19–0.35) [29]
Adjusted for GA not
significant [29]
AIUI [29,37] IVH 65.9% with IVH
had AIUI [37]
No relation [29] Adjusted for GA no
relation [37]
AIUI [37] PDA No relation Stage AIUI
[37] ROP 62.9% with ROP had AIUI Adjusted for GA no
relation
AIUI [37] NEC No relation Stage AIUI




AIUI [29] BPD No relation




[38] Illness severity first
24h
No relation
MVU [26] Low Apgar
score 1 min
OR 1.4–1.7 (1.02–2.5) Apgar ,7 (1+5 min)
MVU [26,32] Neonatal infection No relation
MVU [26,32,40] NEC OR 4 (1.7–9.2) No relation [32,40]
MVU [25,26,32,40] BPD No relation
MVU [26,32] RDS No relation
MVU [26,32,40] PDA No relation
MVU [26,40] ROP No relation
MVU Placental infarction
/abruption
[22] Liver disorders OR 2.2 (1.2–4.2) Only with abruption
MVU [22] Low Apgar score
1 min
No relation
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MVU [22] Neonatal infection No relation
MVU [22] Anomalies* No relation
FTV Fetal thrombotic
vasculopathy
[34] NRFHT OR 3.01 (1.54–5.78)
FTV [34] Fetal cardiac
abnormalities
OR 8.02 (3.02–21.26)
FTV [34] CNS abnormalities No relation
FTV [35] Asphyxia Proportion: 0.26 95% CI
(0.13–0.46)
Proportion FTV






FTV [32,33] NEC OR 4.34–9.10 (1.80–15.08)




FTV [32] RDS No relation
FTV [32] BPD No relation
FTV [32] PDA No relation




[22] Low Apgar score
1 min
No relation
VUE [38] Illness severity first
24h
No relation
VUE [22] Neonatal infection OR 2.3 (1.1–5.1)
VUE [22] Liver disorders No relation
VUE [22] Anomalies* No relation
Deciduitis Chronic
deciduitis






Deciduitis [32] RDS No relation
Deciduitis [25,30,32] BPD No relation
Deciduitis [32] NEC No relation
Deciduitis [30,32] PDA No relation
Deciduitis [30,32] IVH No relation
Deciduitis [30] ROP No relation
UC Umbilical cord
lesions






[24] Apgar 1 min Effect size r=20.09 Lower Apgar scores
UC [24] Apgar 5 min Effect size r=20.07 Lower Apgar scores
UC [24] NRFHS OR 4.91 (1.71–15.91)






[31] Low Apgar 5 min OR 3.14 (1.47–6.70)
UC Overcoiling
umbilical cord
[31] Asphyxia OR 4.16 (1.30–13.36)




Marker [36] LOS No relation
Marker [36] PDA No relation
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process that harmed the vasculature of the placenta causing
infarction, the same process may also have directly harmed either
the fetal cerebral vasculature or the brain.[56]
Results on the association between placental pathology and
long-term neurological outcome, including developmental tests
and functional outcome, are also inconsistent between studies. In














Marker [36] ROP No relation
Marker [36] IVH No relation
Marker Chorangiosis [22] Low Apgar score
1 min
No relation
Marker [38] Illness severity first
24h
No relation
Marker [22] Neonatal infection No relation
Marker [22] Liver disorders No relation
Marker [22] Anomalies* No relation




Other [32] RDS No relation
Other [32] NEC No relation
Other [32] PDA No relation
Other Meconium
staining
[22] Low Apgar score
1 min
No relation
Other [22,32] Neonatal infection No relation
Other [32] RDS No relation
Other [32] BPD No relation
Other [32] NEC No relation
Other [32] PDA OR 0.18 (0.05–0.68)
Other [32] IVH No relation
Other [22] Liver disorders No relation
Other [22] Anomalies No relation
Other Chorionic plate
meconium
[35] Asphyxia Proportion 0.30 95% CI (0.16–0.51)
Other Coagulation
related lesions
[26] NEC OR 2.6 (1.13–6.00)
Other [26] Low Apgar score No relation Apgar 1–5 minutes
Other [26] RDS No relation
Other [26] BPD No relation
Other [26] IVH No relation
Other [26] ROP No relation
Other [26] EOS No relation
Other [26] PDA No relation
Other Placental
ischemic changes
[22] Neonatal infection OR 0.54 (0.35–0.84)
Other [22] Low Apgar score
1 min
No relation
Other [22] Liver disorders No relation
Other [22] Anomalies* No relation
*Anomalies: notations of dysmorphia, hydrocephalus, Down syndrome.
Abbreviations: EOS - early onset sepsis; LOS - late onset sepsis; RDS - respiratory distress syndrome; BPD - bronchopulmonary dysplasia; GA - gestational age; PDA -
patent duct arteriosus; ROP - retinopathy of prematurity; NEC - necrotizing enterocolitis; NRFHT - non-reassuring fetal heart tracing; CNS - central nervous system;
NRFHS - non-reassuring fetal heart status.
Abbreviations placental lesions: AIUI - ascending intrauterine infection; MVU - maternal vascular underperfusion; FTV - fetal thrombotic vasculopathy; VUE - villitis of
unknown etiology; UC - umbilical cord; NRBCs - elevated nucleated red blood cells.
doi:10.1371/journal.pone.0089419.t006
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associated with recent non-occlusive thrombi of the chorionic plate
vessels in combination with chorioamnionitis and severe villous
edema. Chorioamnionitis alone is not associated with neurological
impairment.[41] This was attributed to the strong and consistent
relationship between neurologic impairment and chorionic plate
thrombi that occur only in placentas with chorioamnionitis.[41]
Placental pathology consistent with maternal vascular under-
perfusion was also found to be a risk factor for neurological
impairment, with ORs ranging from 7.4 to 10.1 (95% CI: 1.6–
46.3).[48]
For term infants, Redline et al. reported an association between
neurological impairment and ascending intrauterine infection with
a fetal response (OR 2.9–13.2, 95% CI: 1.2–144).[42,46] In
addition to AIUI with a fetal response, they found that the
following lesions are present significantly more often in placentas
of infants with neurological impairment: meconium associated
vascular necrosis, chorionic vessel thrombi, increased nucleated
red blood cells (sign of fetal hypoxia), findings consistent with
abruption placenta, diffuse chronic villitis, extensive avascular villi,
diffuse chorioamnionic hemosiderosis, and perivillous fibrin.[42]
Neurodevelopmental outcome of preterm-born children at
toddler age is also associated with ascending intrauterine infection
with a fetal response (funisitis). In the presence of funisitis, a higher
incidence of moderate to severe disability is present with an OR of
4.08 (95% CI: 1.16–14.44).[54] In addition, speech abnormalities
and hearing loss are associated with AIUI (ORs 2.9–5.1, 95% CI:
1.2–19.4 and OR 11.6, 95% CI: 1.3–105.9, respectively. A study
comparing neurodevelopmental outcome at two years of age be-
tween very preterm infants with maternal vascular underperfusion
and very preterm infants with histological chorioamnionitis found
poorer mental development in infants with maternal vascular
underperfusion compared to infants with chorioamnionitis.[57]
Neurocognitive outcome of preterm-born children at school age
is associated with villous edema (OR 4.7, 95% CI: 1.1–19.2).
Lower scores on mental processing and on neuropsychological
assessment are found in its presence. In this study, ascending
intrauterine infection is not predictive of impaired neurodevelop-
mental outcome in the population as a whole, but a severe funisitis
is associated with lower scores on neurocognitive tests in the
subpopulations with ascending intrauterine infection.[48]
In summary, despite the difficulties in studying the relation
between placental lesions and neurological morbidity, and the
inconsistent results, some conclusions can be drawn. For those
studies finding a relation with poor neurological outcome, the
placental lesion is ascending intrauterine infection with a fetal
response. Furthermore, in term infants a larger variety of placental
lesions seem to be associated with poor neurological outcome
compared to preterm infants. Knowledge on the pathophysiolog-
ical mechanisms leading to long-term neurological deficits may
lead to possible interventions to improve outcome. The fact that
the placenta is available for histological examination immediately
after birth and that it may reveal valuable information for
pediatricians, leads to an early opportunity to intervene to the
benefit, hopefully, of ill neonates.
Discussion/Conclusion
The placenta plays a key role in fetal and neonatal mortality,
morbidity, and outcome. Placental lesions are one of the main
contributors to fetal death. In these cases placental lesions
consistent with maternal vascular underperfusion are most
important. Although less clear-cut, several neonatal problems are
also associated with placental lesions. Regarding neonatal mor-
bidity and neurological outcome, placental lesions with ascending
intrauterine infection (with a fetal component) and fetal throm-
botic vasculopathy, constitute the greatest problem.
To our surprise we noticed a difference in the description of
placental lesions between studies on perinatal death and studies on
neonatal outcome. The majority of studies on placental pathology
and stillbirth only focus on the presence or absence of placental
lesions in general, but they do not examine the relation between
specific placental lesions and stillbirth. Studies concerning
placental lesions and neonatal or neurological outcome do specify
the lesions, finding several relations between specific placental
lesions and outcome. Characterizing placental lesions in more
detail in stillbirth studies may provide additional information
concerning the cause of death.
Most studies report on associations between placental lesions
and outcomes but this does not necessarily reflect a causal relation.
There is still need to clarify pathophysiological mechanisms. One
of these proposed mechanisms include gene-environment interac-
tions.[92] Placental lesions might already have their onset early in
pregnancy, due to changes in placental genes, leading to epigenetic
alterations. Causes for these placental epigenetic changes may
include a non optimal intrauterine environment, due to a maternal
disease or adverse insults to the intrauterine environment.[93]
This may in turn cause placental dysfunction and hence adverse
neonatal outcome. We thus have to take into account that multiple
interactions from maternal, placental, and fetal health play a role
in the etiology of perinatal death and neonatal morbidity. Future
research must consider statistical tools to better address interac-
tions among these multiple variables, such as a mixed-effect
regression analyses for example.
There are several limitations to our systematic review. Firstly,
there is a potential risk of publication bias. Studies finding negative
results regarding placental lesions and outcome might not be
published. This may lead to an overestimation of associations
between placental lesions and outcomes. Secondly, we included
studies from the past 18 years. Earlier studies might have had
different results. Finally, most studies included in this review were
conducted in high-risk populations. Studies in a low- or moderate-
risk group may reveal different results.
A final point we would like to address is an urgent need for
increasing awareness among pediatricians for placental lesions and
neonatal outcome. The obstetrician sends the placenta to the
pathologist for histological examination. The results of the
examination are reported back to the obstetrician. In most cases
the pediatrician is unaware of the results of the placental
examination. In the light of the accumulating evidence, however,
that placental pathology is associated with perinatal mortality,
neonatal morbidity, and neurological outcome, pediatricians
should make an effort to obtain the results of placental
examinations. Placental pathology, ascending intrauterine infec-
tion, and fetal thrombotic vasculopathy in particular, may help to
identify the group of neonates at risk of adverse neonatal outcome.
Monitoring these infants more closely could be helpful. Knowl-
edge of the pathophysiological mechanisms leading to neonatal
mortality and morbidity may lead the way to finding early
intervention strategies to improve infants’ morbidity and outcome.
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